☆ 4.7 Article

A single arm phase 2 study of talimogene laherparepvec in patients with low-risk invasive cutaneous squamous cell cancer. interim analysis.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 40, Issue 16_suppl, Pages e21583-e21583

Publisher

American Society of Clinical Oncology (ASCO)

DOI: 10.1200/jco.2022.40.16_suppl.e21583

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.